nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—KCNMA1—pulmonary artery—lung cancer	0.053	0.204	CbGeAlD
Hydroflumethiazide—SLC12A3—respiratory system—lung cancer	0.0129	0.0497	CbGeAlD
Hydroflumethiazide—CA5B—mammary gland—lung cancer	0.0115	0.0444	CbGeAlD
Hydroflumethiazide—CA7—trachea—lung cancer	0.00972	0.0375	CbGeAlD
Hydroflumethiazide—ATP1A1—mammary gland—lung cancer	0.00859	0.0332	CbGeAlD
Hydroflumethiazide—CA12—respiratory system—lung cancer	0.00854	0.033	CbGeAlD
Hydroflumethiazide—SLC12A1—epithelium—lung cancer	0.00822	0.0317	CbGeAlD
Hydroflumethiazide—CA14—cardiac atrium—lung cancer	0.0076	0.0294	CbGeAlD
Hydroflumethiazide—KCNMA1—epithelium—lung cancer	0.00745	0.0287	CbGeAlD
Hydroflumethiazide—SLC12A3—lung—lung cancer	0.00684	0.0264	CbGeAlD
Hydroflumethiazide—CA1—respiratory system—lung cancer	0.00677	0.0261	CbGeAlD
Hydroflumethiazide—CA12—trachea—lung cancer	0.00631	0.0244	CbGeAlD
Hydroflumethiazide—ATP1A1—respiratory system—lung cancer	0.00572	0.0221	CbGeAlD
Hydroflumethiazide—CA5B—cardiac atrium—lung cancer	0.00532	0.0205	CbGeAlD
Hydroflumethiazide—CA4—respiratory system—lung cancer	0.00529	0.0204	CbGeAlD
Hydroflumethiazide—ATP1A1—epithelium—lung cancer	0.00478	0.0185	CbGeAlD
Hydroflumethiazide—KCNMA1—lung—lung cancer	0.00473	0.0183	CbGeAlD
Hydroflumethiazide—ATP1A1—bronchus—lung cancer	0.00471	0.0182	CbGeAlD
Hydroflumethiazide—CA12—lung—lung cancer	0.00454	0.0175	CbGeAlD
Hydroflumethiazide—CA2—respiratory system—lung cancer	0.00439	0.0169	CbGeAlD
Hydroflumethiazide—ATP1A1—trachea—lung cancer	0.00423	0.0163	CbGeAlD
Hydroflumethiazide—CA5B—lung—lung cancer	0.00407	0.0157	CbGeAlD
Hydroflumethiazide—ATP1A1—cardiac atrium—lung cancer	0.00397	0.0153	CbGeAlD
Hydroflumethiazide—CA1—bone marrow—lung cancer	0.00397	0.0153	CbGeAlD
Hydroflumethiazide—CA4—trachea—lung cancer	0.00391	0.0151	CbGeAlD
Hydroflumethiazide—CA4—cardiac atrium—lung cancer	0.00367	0.0142	CbGeAlD
Hydroflumethiazide—CA2—epithelium—lung cancer	0.00367	0.0141	CbGeAlD
Hydroflumethiazide—CA2—bronchus—lung cancer	0.00361	0.0139	CbGeAlD
Hydroflumethiazide—CA1—lung—lung cancer	0.00359	0.0139	CbGeAlD
Hydroflumethiazide—ATP1A1—bone marrow—lung cancer	0.00335	0.0129	CbGeAlD
Hydroflumethiazide—CA2—trachea—lung cancer	0.00324	0.0125	CbGeAlD
Hydroflumethiazide—KCNMA1—lymph node—lung cancer	0.00324	0.0125	CbGeAlD
Hydroflumethiazide—CA4—bone marrow—lung cancer	0.0031	0.012	CbGeAlD
Hydroflumethiazide—CA2—cardiac atrium—lung cancer	0.00305	0.0118	CbGeAlD
Hydroflumethiazide—ATP1A1—lung—lung cancer	0.00304	0.0117	CbGeAlD
Hydroflumethiazide—CA4—lung—lung cancer	0.00281	0.0108	CbGeAlD
Hydroflumethiazide—CA5B—lymph node—lung cancer	0.00278	0.0107	CbGeAlD
Hydroflumethiazide—CA2—bone marrow—lung cancer	0.00257	0.00992	CbGeAlD
Hydroflumethiazide—Hypersensitivity—Gefitinib—lung cancer	0.00247	0.00508	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Irinotecan—lung cancer	0.00246	0.00507	CcSEcCtD
Hydroflumethiazide—CA1—lymph node—lung cancer	0.00246	0.00949	CbGeAlD
Hydroflumethiazide—Dizziness—Crizotinib—lung cancer	0.00244	0.00502	CcSEcCtD
Hydroflumethiazide—Asthenia—Pemetrexed—lung cancer	0.00242	0.00498	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Cisplatin—lung cancer	0.00241	0.00496	CcSEcCtD
Hydroflumethiazide—Asthenia—Gefitinib—lung cancer	0.0024	0.00495	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Topotecan—lung cancer	0.00238	0.00491	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Cisplatin—lung cancer	0.00237	0.00489	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Teniposide—lung cancer	0.00237	0.00489	CcSEcCtD
Hydroflumethiazide—Vomiting—Crizotinib—lung cancer	0.00234	0.00483	CcSEcCtD
Hydroflumethiazide—CA2—lung—lung cancer	0.00233	0.00899	CbGeAlD
Hydroflumethiazide—Rash—Crizotinib—lung cancer	0.00232	0.00479	CcSEcCtD
Hydroflumethiazide—Dermatitis—Crizotinib—lung cancer	0.00232	0.00479	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Pemetrexed—lung cancer	0.0023	0.00475	CcSEcCtD
Hydroflumethiazide—Vertigo—Vinblastine—lung cancer	0.00229	0.00472	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Gefitinib—lung cancer	0.00229	0.00472	CcSEcCtD
Hydroflumethiazide—Leukopenia—Vinblastine—lung cancer	0.00228	0.00471	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Cisplatin—lung cancer	0.00223	0.0046	CcSEcCtD
Hydroflumethiazide—Dizziness—Pemetrexed—lung cancer	0.00223	0.00459	CcSEcCtD
Hydroflumethiazide—Leukopenia—Topotecan—lung cancer	0.00222	0.00457	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Gemcitabine—lung cancer	0.0022	0.00455	CcSEcCtD
Hydroflumethiazide—Nausea—Crizotinib—lung cancer	0.00219	0.00451	CcSEcCtD
Hydroflumethiazide—Jaundice—Irinotecan—lung cancer	0.00218	0.0045	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Etoposide—lung cancer	0.00217	0.00448	CcSEcCtD
Hydroflumethiazide—Urticaria—Teniposide—lung cancer	0.00217	0.00447	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Paclitaxel—lung cancer	0.00216	0.00446	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Methotrexate—lung cancer	0.00215	0.00443	CcSEcCtD
Hydroflumethiazide—Vomiting—Pemetrexed—lung cancer	0.00214	0.00442	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Paclitaxel—lung cancer	0.00213	0.0044	CcSEcCtD
Hydroflumethiazide—Glycosuria—Doxorubicin—lung cancer	0.00213	0.00439	CcSEcCtD
Hydroflumethiazide—Vomiting—Gefitinib—lung cancer	0.00213	0.00439	CcSEcCtD
Hydroflumethiazide—Rash—Pemetrexed—lung cancer	0.00212	0.00438	CcSEcCtD
Hydroflumethiazide—Dermatitis—Pemetrexed—lung cancer	0.00212	0.00437	CcSEcCtD
Hydroflumethiazide—Rash—Gefitinib—lung cancer	0.00211	0.00435	CcSEcCtD
Hydroflumethiazide—Dermatitis—Gefitinib—lung cancer	0.00211	0.00435	CcSEcCtD
Hydroflumethiazide—ATP1A1—lymph node—lung cancer	0.00208	0.00802	CbGeAlD
Hydroflumethiazide—Vasculitis—Methotrexate—lung cancer	0.00204	0.00421	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Vinblastine—lung cancer	0.00204	0.0042	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Gemcitabine—lung cancer	0.00203	0.00419	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Methotrexate—lung cancer	0.00203	0.00418	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Teniposide—lung cancer	0.00201	0.00414	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Paclitaxel—lung cancer	0.00201	0.00414	CcSEcCtD
Hydroflumethiazide—Nausea—Pemetrexed—lung cancer	0.002	0.00412	CcSEcCtD
Hydroflumethiazide—Nausea—Gefitinib—lung cancer	0.00199	0.0041	CcSEcCtD
Hydroflumethiazide—Anorexia—Vinblastine—lung cancer	0.00198	0.00409	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Topotecan—lung cancer	0.00198	0.00408	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Doxorubicin—lung cancer	0.00196	0.00405	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Erlotinib—lung cancer	0.00196	0.00404	CcSEcCtD
Hydroflumethiazide—Asthenia—Teniposide—lung cancer	0.00196	0.00404	CcSEcCtD
Hydroflumethiazide—Anorexia—Topotecan—lung cancer	0.00193	0.00397	CcSEcCtD
Hydroflumethiazide—CA4—lymph node—lung cancer	0.00192	0.00741	CbGeAlD
Hydroflumethiazide—Anorexia—Erlotinib—lung cancer	0.00191	0.00393	CcSEcCtD
Hydroflumethiazide—Vertigo—Vinorelbine—lung cancer	0.0019	0.00393	CcSEcCtD
Hydroflumethiazide—Leukopenia—Vinorelbine—lung cancer	0.0019	0.00391	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Methotrexate—lung cancer	0.00187	0.00386	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Paclitaxel—lung cancer	0.00187	0.00385	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Teniposide—lung cancer	0.00187	0.00385	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Doxorubicin—lung cancer	0.00186	0.00383	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Paclitaxel—lung cancer	0.00185	0.00381	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Docetaxel—lung cancer	0.00183	0.00378	CcSEcCtD
Hydroflumethiazide—Jaundice—Etoposide—lung cancer	0.00181	0.00374	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Vinblastine—lung cancer	0.00181	0.00373	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Docetaxel—lung cancer	0.00181	0.00373	CcSEcCtD
Hydroflumethiazide—Constipation—Vinblastine—lung cancer	0.00178	0.00367	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Topotecan—lung cancer	0.00176	0.00362	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Doxorubicin—lung cancer	0.00176	0.00362	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Erlotinib—lung cancer	0.00174	0.00359	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Etoposide—lung cancer	0.00174	0.00358	CcSEcCtD
Hydroflumethiazide—Vomiting—Teniposide—lung cancer	0.00173	0.00358	CcSEcCtD
Hydroflumethiazide—Constipation—Topotecan—lung cancer	0.00173	0.00357	CcSEcCtD
Hydroflumethiazide—Rash—Teniposide—lung cancer	0.00172	0.00355	CcSEcCtD
Hydroflumethiazide—Dermatitis—Teniposide—lung cancer	0.00172	0.00354	CcSEcCtD
Hydroflumethiazide—Constipation—Erlotinib—lung cancer	0.00171	0.00353	CcSEcCtD
Hydroflumethiazide—Headache—Teniposide—lung cancer	0.00171	0.00352	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Vinorelbine—lung cancer	0.00169	0.00349	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Irinotecan—lung cancer	0.00168	0.00347	CcSEcCtD
Hydroflumethiazide—Anorexia—Vinorelbine—lung cancer	0.00165	0.0034	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Methotrexate—lung cancer	0.00165	0.0034	CcSEcCtD
Hydroflumethiazide—Nausea—Teniposide—lung cancer	0.00162	0.00334	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Doxorubicin—lung cancer	0.00162	0.00334	CcSEcCtD
Hydroflumethiazide—Urticaria—Topotecan—lung cancer	0.00161	0.00331	CcSEcCtD
Hydroflumethiazide—CA2—lymph node—lung cancer	0.00159	0.00615	CbGeAlD
Hydroflumethiazide—Vertigo—Irinotecan—lung cancer	0.00157	0.00324	CcSEcCtD
Hydroflumethiazide—Leukopenia—Irinotecan—lung cancer	0.00156	0.00323	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Vinblastine—lung cancer	0.00153	0.00316	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Cisplatin—lung cancer	0.00153	0.00315	CcSEcCtD
Hydroflumethiazide—Leukopenia—Gemcitabine—lung cancer	0.00152	0.00314	CcSEcCtD
Hydroflumethiazide—Jaundice—Docetaxel—lung cancer	0.00151	0.00311	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Vinorelbine—lung cancer	0.0015	0.0031	CcSEcCtD
Hydroflumethiazide—Asthenia—Vinblastine—lung cancer	0.00149	0.00308	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Topotecan—lung cancer	0.00149	0.00307	CcSEcCtD
Hydroflumethiazide—Constipation—Vinorelbine—lung cancer	0.00148	0.00305	CcSEcCtD
Hydroflumethiazide—Asthenia—Topotecan—lung cancer	0.00145	0.00299	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Docetaxel—lung cancer	0.00144	0.00298	CcSEcCtD
Hydroflumethiazide—Asthenia—Erlotinib—lung cancer	0.00144	0.00296	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Doxorubicin—lung cancer	0.00143	0.00294	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vinblastine—lung cancer	0.00142	0.00294	CcSEcCtD
Hydroflumethiazide—Leukopenia—Cisplatin—lung cancer	0.00142	0.00293	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Doxorubicin—lung cancer	0.0014	0.00289	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Etoposide—lung cancer	0.0014	0.00288	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Irinotecan—lung cancer	0.0014	0.00288	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Topotecan—lung cancer	0.00138	0.00285	CcSEcCtD
Hydroflumethiazide—Dizziness—Vinblastine—lung cancer	0.00138	0.00284	CcSEcCtD
Hydroflumethiazide—Urticaria—Vinorelbine—lung cancer	0.00137	0.00283	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Paclitaxel—lung cancer	0.00137	0.00283	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Erlotinib—lung cancer	0.00137	0.00282	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Gemcitabine—lung cancer	0.00136	0.00281	CcSEcCtD
Hydroflumethiazide—Anorexia—Irinotecan—lung cancer	0.00136	0.0028	CcSEcCtD
Hydroflumethiazide—Dizziness—Topotecan—lung cancer	0.00134	0.00276	CcSEcCtD
Hydroflumethiazide—Anorexia—Gemcitabine—lung cancer	0.00132	0.00273	CcSEcCtD
Hydroflumethiazide—Vomiting—Vinblastine—lung cancer	0.00132	0.00273	CcSEcCtD
Hydroflumethiazide—Dizziness—Erlotinib—lung cancer	0.00132	0.00273	CcSEcCtD
Hydroflumethiazide—Agitation—Paclitaxel—lung cancer	0.00131	0.0027	CcSEcCtD
Hydroflumethiazide—Vertigo—Etoposide—lung cancer	0.00131	0.00269	CcSEcCtD
Hydroflumethiazide—Headache—Vinblastine—lung cancer	0.0013	0.00269	CcSEcCtD
Hydroflumethiazide—Leukopenia—Etoposide—lung cancer	0.0013	0.00268	CcSEcCtD
Hydroflumethiazide—Purpura—Doxorubicin—lung cancer	0.0013	0.00268	CcSEcCtD
Hydroflumethiazide—Vomiting—Topotecan—lung cancer	0.00129	0.00265	CcSEcCtD
Hydroflumethiazide—Vertigo—Paclitaxel—lung cancer	0.00128	0.00264	CcSEcCtD
Hydroflumethiazide—Leukopenia—Paclitaxel—lung cancer	0.00128	0.00263	CcSEcCtD
Hydroflumethiazide—Rash—Topotecan—lung cancer	0.00127	0.00263	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Vinorelbine—lung cancer	0.00127	0.00263	CcSEcCtD
Hydroflumethiazide—Dermatitis—Topotecan—lung cancer	0.00127	0.00263	CcSEcCtD
Hydroflumethiazide—Vomiting—Erlotinib—lung cancer	0.00127	0.00262	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Cisplatin—lung cancer	0.00127	0.00261	CcSEcCtD
Hydroflumethiazide—Headache—Topotecan—lung cancer	0.00127	0.00261	CcSEcCtD
Hydroflumethiazide—Rash—Erlotinib—lung cancer	0.00126	0.0026	CcSEcCtD
Hydroflumethiazide—Dermatitis—Erlotinib—lung cancer	0.00126	0.0026	CcSEcCtD
Hydroflumethiazide—Headache—Erlotinib—lung cancer	0.00125	0.00258	CcSEcCtD
Hydroflumethiazide—Asthenia—Vinorelbine—lung cancer	0.00124	0.00256	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Irinotecan—lung cancer	0.00124	0.00256	CcSEcCtD
Hydroflumethiazide—Nausea—Vinblastine—lung cancer	0.00124	0.00255	CcSEcCtD
Hydroflumethiazide—Anorexia—Cisplatin—lung cancer	0.00123	0.00255	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Methotrexate—lung cancer	0.00123	0.00253	CcSEcCtD
Hydroflumethiazide—Constipation—Irinotecan—lung cancer	0.00122	0.00252	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Gemcitabine—lung cancer	0.00121	0.00249	CcSEcCtD
Hydroflumethiazide—Nausea—Topotecan—lung cancer	0.0012	0.00248	CcSEcCtD
Hydroflumethiazide—Constipation—Gemcitabine—lung cancer	0.00119	0.00245	CcSEcCtD
Hydroflumethiazide—Nausea—Erlotinib—lung cancer	0.00119	0.00245	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vinorelbine—lung cancer	0.00118	0.00244	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Etoposide—lung cancer	0.00116	0.0024	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Docetaxel—lung cancer	0.00116	0.0024	CcSEcCtD
Hydroflumethiazide—Dizziness—Vinorelbine—lung cancer	0.00114	0.00236	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Doxorubicin—lung cancer	0.00114	0.00236	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Methotrexate—lung cancer	0.00114	0.00235	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Paclitaxel—lung cancer	0.00114	0.00235	CcSEcCtD
Hydroflumethiazide—Anorexia—Etoposide—lung cancer	0.00113	0.00233	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Cisplatin—lung cancer	0.00113	0.00232	CcSEcCtD
Hydroflumethiazide—Anorexia—Paclitaxel—lung cancer	0.00111	0.00229	CcSEcCtD
Hydroflumethiazide—Vomiting—Vinorelbine—lung cancer	0.0011	0.00227	CcSEcCtD
Hydroflumethiazide—Rash—Vinorelbine—lung cancer	0.00109	0.00225	CcSEcCtD
Hydroflumethiazide—Dermatitis—Vinorelbine—lung cancer	0.00109	0.00225	CcSEcCtD
Hydroflumethiazide—Headache—Vinorelbine—lung cancer	0.00108	0.00223	CcSEcCtD
Hydroflumethiazide—Leukopenia—Docetaxel—lung cancer	0.00108	0.00223	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Doxorubicin—lung cancer	0.00106	0.00219	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Irinotecan—lung cancer	0.00105	0.00217	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Methotrexate—lung cancer	0.00104	0.00214	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Etoposide—lung cancer	0.00103	0.00213	CcSEcCtD
Hydroflumethiazide—Nausea—Vinorelbine—lung cancer	0.00103	0.00212	CcSEcCtD
Hydroflumethiazide—Asthenia—Irinotecan—lung cancer	0.00102	0.00211	CcSEcCtD
Hydroflumethiazide—Constipation—Etoposide—lung cancer	0.00101	0.00209	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Paclitaxel—lung cancer	0.00101	0.00209	CcSEcCtD
Hydroflumethiazide—Asthenia—Gemcitabine—lung cancer	0.000997	0.00206	CcSEcCtD
Hydroflumethiazide—Constipation—Paclitaxel—lung cancer	0.000995	0.00205	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Doxorubicin—lung cancer	0.000988	0.00204	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Doxorubicin—lung cancer	0.000976	0.00201	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Irinotecan—lung cancer	0.000976	0.00201	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Docetaxel—lung cancer	0.000966	0.00199	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Cisplatin—lung cancer	0.000954	0.00197	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Gemcitabine—lung cancer	0.000951	0.00196	CcSEcCtD
Hydroflumethiazide—Dizziness—Irinotecan—lung cancer	0.000943	0.00195	CcSEcCtD
Hydroflumethiazide—Urticaria—Etoposide—lung cancer	0.000943	0.00194	CcSEcCtD
Hydroflumethiazide—Jaundice—Doxorubicin—lung cancer	0.000941	0.00194	CcSEcCtD
Hydroflumethiazide—Anorexia—Docetaxel—lung cancer	0.00094	0.00194	CcSEcCtD
Hydroflumethiazide—Asthenia—Cisplatin—lung cancer	0.000929	0.00192	CcSEcCtD
Hydroflumethiazide—Urticaria—Paclitaxel—lung cancer	0.000924	0.00191	CcSEcCtD
Hydroflumethiazide—Vomiting—Irinotecan—lung cancer	0.000907	0.00187	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Doxorubicin—lung cancer	0.0009	0.00186	CcSEcCtD
Hydroflumethiazide—Rash—Irinotecan—lung cancer	0.000899	0.00185	CcSEcCtD
Hydroflumethiazide—Dermatitis—Irinotecan—lung cancer	0.000899	0.00185	CcSEcCtD
Hydroflumethiazide—Headache—Irinotecan—lung cancer	0.000894	0.00184	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Cisplatin—lung cancer	0.000886	0.00183	CcSEcCtD
Hydroflumethiazide—Vomiting—Gemcitabine—lung cancer	0.000884	0.00182	CcSEcCtD
Hydroflumethiazide—Rash—Gemcitabine—lung cancer	0.000876	0.00181	CcSEcCtD
Hydroflumethiazide—Dermatitis—Gemcitabine—lung cancer	0.000875	0.0018	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Etoposide—lung cancer	0.000874	0.0018	CcSEcCtD
Hydroflumethiazide—Headache—Gemcitabine—lung cancer	0.000871	0.00179	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Docetaxel—lung cancer	0.000857	0.00177	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Paclitaxel—lung cancer	0.000857	0.00177	CcSEcCtD
Hydroflumethiazide—Asthenia—Etoposide—lung cancer	0.000851	0.00176	CcSEcCtD
Hydroflumethiazide—Nausea—Irinotecan—lung cancer	0.000847	0.00175	CcSEcCtD
Hydroflumethiazide—Constipation—Docetaxel—lung cancer	0.000843	0.00174	CcSEcCtD
Hydroflumethiazide—Asthenia—Paclitaxel—lung cancer	0.000835	0.00172	CcSEcCtD
Hydroflumethiazide—Nausea—Gemcitabine—lung cancer	0.000825	0.0017	CcSEcCtD
Hydroflumethiazide—Vomiting—Cisplatin—lung cancer	0.000824	0.0017	CcSEcCtD
Hydroflumethiazide—Rash—Cisplatin—lung cancer	0.000817	0.00168	CcSEcCtD
Hydroflumethiazide—Dermatitis—Cisplatin—lung cancer	0.000816	0.00168	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Etoposide—lung cancer	0.000812	0.00167	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Paclitaxel—lung cancer	0.000796	0.00164	CcSEcCtD
Hydroflumethiazide—Dizziness—Etoposide—lung cancer	0.000785	0.00162	CcSEcCtD
Hydroflumethiazide—Vertigo—Methotrexate—lung cancer	0.000782	0.00161	CcSEcCtD
Hydroflumethiazide—Leukopenia—Methotrexate—lung cancer	0.00078	0.00161	CcSEcCtD
Hydroflumethiazide—Dizziness—Paclitaxel—lung cancer	0.000769	0.00159	CcSEcCtD
Hydroflumethiazide—Nausea—Cisplatin—lung cancer	0.000769	0.00159	CcSEcCtD
Hydroflumethiazide—Vomiting—Etoposide—lung cancer	0.000754	0.00156	CcSEcCtD
Hydroflumethiazide—Rash—Etoposide—lung cancer	0.000748	0.00154	CcSEcCtD
Hydroflumethiazide—Dermatitis—Etoposide—lung cancer	0.000747	0.00154	CcSEcCtD
Hydroflumethiazide—Headache—Etoposide—lung cancer	0.000743	0.00153	CcSEcCtD
Hydroflumethiazide—Vomiting—Paclitaxel—lung cancer	0.00074	0.00153	CcSEcCtD
Hydroflumethiazide—Rash—Paclitaxel—lung cancer	0.000734	0.00151	CcSEcCtD
Hydroflumethiazide—Dermatitis—Paclitaxel—lung cancer	0.000733	0.00151	CcSEcCtD
Hydroflumethiazide—Headache—Paclitaxel—lung cancer	0.000729	0.0015	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Docetaxel—lung cancer	0.000727	0.0015	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Doxorubicin—lung cancer	0.000725	0.00149	CcSEcCtD
Hydroflumethiazide—Asthenia—Docetaxel—lung cancer	0.000708	0.00146	CcSEcCtD
Hydroflumethiazide—Nausea—Etoposide—lung cancer	0.000705	0.00145	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Methotrexate—lung cancer	0.000696	0.00143	CcSEcCtD
Hydroflumethiazide—Agitation—Doxorubicin—lung cancer	0.000693	0.00143	CcSEcCtD
Hydroflumethiazide—Nausea—Paclitaxel—lung cancer	0.000691	0.00142	CcSEcCtD
Hydroflumethiazide—Vertigo—Doxorubicin—lung cancer	0.000677	0.0014	CcSEcCtD
Hydroflumethiazide—Anorexia—Methotrexate—lung cancer	0.000677	0.0014	CcSEcCtD
Hydroflumethiazide—Leukopenia—Doxorubicin—lung cancer	0.000675	0.00139	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Docetaxel—lung cancer	0.000675	0.00139	CcSEcCtD
Hydroflumethiazide—Dizziness—Docetaxel—lung cancer	0.000652	0.00134	CcSEcCtD
Hydroflumethiazide—Vomiting—Docetaxel—lung cancer	0.000627	0.00129	CcSEcCtD
Hydroflumethiazide—Rash—Docetaxel—lung cancer	0.000622	0.00128	CcSEcCtD
Hydroflumethiazide—Dermatitis—Docetaxel—lung cancer	0.000621	0.00128	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Methotrexate—lung cancer	0.000618	0.00127	CcSEcCtD
Hydroflumethiazide—Headache—Docetaxel—lung cancer	0.000618	0.00127	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Doxorubicin—lung cancer	0.000603	0.00124	CcSEcCtD
Hydroflumethiazide—Anorexia—Doxorubicin—lung cancer	0.000587	0.00121	CcSEcCtD
Hydroflumethiazide—Nausea—Docetaxel—lung cancer	0.000586	0.00121	CcSEcCtD
Hydroflumethiazide—Urticaria—Methotrexate—lung cancer	0.000565	0.00116	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Doxorubicin—lung cancer	0.000535	0.0011	CcSEcCtD
Hydroflumethiazide—Constipation—Doxorubicin—lung cancer	0.000526	0.00109	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Methotrexate—lung cancer	0.000524	0.00108	CcSEcCtD
Hydroflumethiazide—Asthenia—Methotrexate—lung cancer	0.00051	0.00105	CcSEcCtD
Hydroflumethiazide—Urticaria—Doxorubicin—lung cancer	0.000489	0.00101	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Methotrexate—lung cancer	0.000486	0.001	CcSEcCtD
Hydroflumethiazide—Dizziness—Methotrexate—lung cancer	0.00047	0.000969	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Doxorubicin—lung cancer	0.000453	0.000935	CcSEcCtD
Hydroflumethiazide—Vomiting—Methotrexate—lung cancer	0.000452	0.000932	CcSEcCtD
Hydroflumethiazide—Rash—Methotrexate—lung cancer	0.000448	0.000924	CcSEcCtD
Hydroflumethiazide—Dermatitis—Methotrexate—lung cancer	0.000448	0.000923	CcSEcCtD
Hydroflumethiazide—Headache—Methotrexate—lung cancer	0.000445	0.000918	CcSEcCtD
Hydroflumethiazide—Asthenia—Doxorubicin—lung cancer	0.000442	0.00091	CcSEcCtD
Hydroflumethiazide—Nausea—Methotrexate—lung cancer	0.000422	0.00087	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Doxorubicin—lung cancer	0.000421	0.000868	CcSEcCtD
Hydroflumethiazide—Dizziness—Doxorubicin—lung cancer	0.000407	0.000839	CcSEcCtD
Hydroflumethiazide—Vomiting—Doxorubicin—lung cancer	0.000391	0.000807	CcSEcCtD
Hydroflumethiazide—Rash—Doxorubicin—lung cancer	0.000388	0.0008	CcSEcCtD
Hydroflumethiazide—Dermatitis—Doxorubicin—lung cancer	0.000388	0.000799	CcSEcCtD
Hydroflumethiazide—Headache—Doxorubicin—lung cancer	0.000386	0.000795	CcSEcCtD
Hydroflumethiazide—Nausea—Doxorubicin—lung cancer	0.000366	0.000754	CcSEcCtD
Hydroflumethiazide—KCNMA1—Hemostasis—ALB—lung cancer	0.0002	0.00078	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—lung cancer	0.000199	0.000778	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTA2—lung cancer	0.000196	0.000766	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—JUN—lung cancer	0.000195	0.000762	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000195	0.000761	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000195	0.000761	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NCOA3—lung cancer	0.000194	0.000758	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GNG11—lung cancer	0.000193	0.000754	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALDOA—lung cancer	0.000192	0.000749	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTA1—lung cancer	0.000189	0.000739	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP2E1—lung cancer	0.000189	0.000739	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CDKN1A—lung cancer	0.000189	0.000738	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ADCY1—lung cancer	0.000189	0.000738	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ABCG2—lung cancer	0.000189	0.000738	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ABCC3—lung cancer	0.000187	0.000731	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NQO1—lung cancer	0.000187	0.000731	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NCOA3—lung cancer	0.000186	0.000727	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTP1—lung cancer	0.000185	0.000723	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ENO2—lung cancer	0.000185	0.000723	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—HPGDS—lung cancer	0.000185	0.000723	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PPP2R1B—lung cancer	0.000184	0.000719	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALDOA—lung cancer	0.000184	0.000718	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ALB—lung cancer	0.000182	0.000713	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—ALB—lung cancer	0.000182	0.000713	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—STK11—lung cancer	0.000182	0.000711	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—STK11—lung cancer	0.000182	0.000711	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—RAF1—lung cancer	0.000182	0.00071	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AKR1C1—lung cancer	0.000181	0.000708	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ADCY1—lung cancer	0.000181	0.000707	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ABCG2—lung cancer	0.000181	0.000707	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—RAF1—lung cancer	0.000181	0.000706	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CAT—lung cancer	0.00018	0.000704	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—EP300—lung cancer	0.00018	0.000703	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTT1—lung cancer	0.00018	0.000702	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NCOA3—lung cancer	0.000178	0.000697	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ENO2—lung cancer	0.000177	0.000693	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GCLC—lung cancer	0.000177	0.000693	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—HPGDS—lung cancer	0.000177	0.000693	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP2A6—lung cancer	0.000177	0.000693	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PPP2R1B—lung cancer	0.000176	0.000689	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CB—lung cancer	0.000176	0.000689	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—UGT1A1—lung cancer	0.000176	0.000687	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ABCB1—lung cancer	0.000175	0.000685	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ABCG2—lung cancer	0.000173	0.000678	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ADCY1—lung cancer	0.000173	0.000678	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—TYMS—lung cancer	0.000172	0.000673	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTT1—lung cancer	0.000172	0.000673	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—VEGFA—lung cancer	0.00017	0.000666	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—HPGDS—lung cancer	0.00017	0.000665	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ENO2—lung cancer	0.00017	0.000665	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GCLC—lung cancer	0.00017	0.000665	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP2A6—lung cancer	0.00017	0.000665	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTM1—lung cancer	0.00017	0.000665	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GNG11—lung cancer	0.00017	0.000663	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PPP2R1B—lung cancer	0.000169	0.000661	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—STK11—lung cancer	0.000169	0.000659	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—STAT3—lung cancer	0.000169	0.000659	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTP1—lung cancer	0.000168	0.000658	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTP1—lung cancer	0.000168	0.000658	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ENO1—lung cancer	0.000168	0.000657	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTT1—lung cancer	0.000165	0.000645	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—RAF1—lung cancer	0.000165	0.000644	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—RAF1—lung cancer	0.000165	0.000644	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CAT—lung cancer	0.000164	0.00064	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CAT—lung cancer	0.000164	0.00064	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GCLC—lung cancer	0.000163	0.000637	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP2A6—lung cancer	0.000163	0.000637	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IL2—lung cancer	0.000162	0.000633	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALDOA—lung cancer	0.000161	0.000631	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ENO1—lung cancer	0.000161	0.00063	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYP1A1—lung cancer	0.000161	0.00063	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—MAPK3—lung cancer	0.000161	0.00063	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—HRAS—lung cancer	0.00016	0.000626	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ERCC2—lung cancer	0.00016	0.000625	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ABCB1—lung cancer	0.000159	0.000623	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ABCB1—lung cancer	0.000159	0.000623	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOA3—lung cancer	0.000157	0.000613	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—TYMS—lung cancer	0.000157	0.000612	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—TYMS—lung cancer	0.000157	0.000612	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTP1—lung cancer	0.000156	0.00061	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTM1—lung cancer	0.000155	0.000605	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTM1—lung cancer	0.000155	0.000605	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ENO1—lung cancer	0.000155	0.000604	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ABCG2—lung cancer	0.000153	0.000596	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ADCY1—lung cancer	0.000153	0.000596	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CAT—lung cancer	0.000152	0.000593	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP2E1—lung cancer	0.000151	0.00059	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HPGDS—lung cancer	0.00015	0.000584	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ENO2—lung cancer	0.00015	0.000584	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NQO1—lung cancer	0.000149	0.000583	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PPP2R1B—lung cancer	0.000149	0.000581	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ABCB1—lung cancer	0.000148	0.000577	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYP1A1—lung cancer	0.000147	0.000573	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP1A1—lung cancer	0.000147	0.000573	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ERCC2—lung cancer	0.000146	0.000569	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ERCC2—lung cancer	0.000146	0.000569	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—EP300—lung cancer	0.000145	0.000568	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTT1—lung cancer	0.000145	0.000567	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—TYMS—lung cancer	0.000145	0.000567	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP2E1—lung cancer	0.000145	0.000565	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP2A6—lung cancer	0.000143	0.00056	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GCLC—lung cancer	0.000143	0.00056	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTM1—lung cancer	0.000143	0.00056	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NQO1—lung cancer	0.000143	0.000559	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SRC—lung cancer	0.000141	0.000552	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP2E1—lung cancer	0.000139	0.000542	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—APOA1—lung cancer	0.000138	0.000541	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—VEGFA—lung cancer	0.000138	0.000538	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NQO1—lung cancer	0.000137	0.000536	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—NRAS—lung cancer	0.000136	0.000531	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ENO1—lung cancer	0.000136	0.000531	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP1A1—lung cancer	0.000136	0.000531	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ERCC2—lung cancer	0.000135	0.000527	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—STK11—lung cancer	0.000134	0.000526	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—MAPK3—lung cancer	0.00013	0.000509	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—STK11—lung cancer	0.000129	0.000504	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—TP53—lung cancer	0.000129	0.000503	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CG—lung cancer	0.000126	0.000494	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—APOA1—lung cancer	0.000126	0.000492	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—APOA1—lung cancer	0.000126	0.000492	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTP1—lung cancer	0.000124	0.000486	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—STK11—lung cancer	0.000124	0.000483	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP2E1—lung cancer	0.000122	0.000476	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CAT—lung cancer	0.000121	0.000473	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NQO1—lung cancer	0.000121	0.000471	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—POMC—lung cancer	0.00012	0.00047	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTP1—lung cancer	0.000119	0.000466	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—IL6—lung cancer	0.000118	0.00046	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ABCB1—lung cancer	0.000118	0.00046	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CREBBP—lung cancer	0.000117	0.000458	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—KRAS—lung cancer	0.000117	0.000457	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—APOA1—lung cancer	0.000117	0.000456	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CAT—lung cancer	0.000116	0.000454	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TYMS—lung cancer	0.000116	0.000452	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CG—lung cancer	0.000115	0.000449	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CG—lung cancer	0.000115	0.000449	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTP1—lung cancer	0.000114	0.000447	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTM1—lung cancer	0.000114	0.000447	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ABCB1—lung cancer	0.000113	0.000441	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CAT—lung cancer	0.000111	0.000435	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CD—lung cancer	0.000111	0.000434	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TYMS—lung cancer	0.000111	0.000433	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTM1—lung cancer	0.00011	0.000428	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ALB—lung cancer	0.00011	0.000428	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—POMC—lung cancer	0.000109	0.000427	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—POMC—lung cancer	0.000109	0.000427	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—STK11—lung cancer	0.000109	0.000425	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP1A1—lung cancer	0.000108	0.000424	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ABCB1—lung cancer	0.000108	0.000423	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ERCC2—lung cancer	0.000108	0.00042	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CA—lung cancer	0.000107	0.00042	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CREBBP—lung cancer	0.000107	0.000416	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CREBBP—lung cancer	0.000107	0.000416	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CG—lung cancer	0.000106	0.000416	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TYMS—lung cancer	0.000106	0.000416	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTM1—lung cancer	0.000105	0.000411	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TP53—lung cancer	0.000104	0.000406	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP1A1—lung cancer	0.000104	0.000406	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ERCC2—lung cancer	0.000103	0.000403	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—POMC—lung cancer	0.000101	0.000396	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CD—lung cancer	0.000101	0.000395	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CD—lung cancer	0.000101	0.000395	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTP1—lung cancer	0.000101	0.000393	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ALB—lung cancer	9.97e-05	0.00039	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ALB—lung cancer	9.97e-05	0.00039	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP1A1—lung cancer	9.96e-05	0.000389	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—HRAS—lung cancer	9.94e-05	0.000389	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ERCC2—lung cancer	9.88e-05	0.000386	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CREBBP—lung cancer	9.87e-05	0.000386	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CAT—lung cancer	9.78e-05	0.000382	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CB—lung cancer	9.68e-05	0.000378	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTGS2—lung cancer	9.59e-05	0.000375	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ABCB1—lung cancer	9.52e-05	0.000372	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CD—lung cancer	9.36e-05	0.000366	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TYMS—lung cancer	9.35e-05	0.000365	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—APOA1—lung cancer	9.3e-05	0.000363	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTM1—lung cancer	9.24e-05	0.000361	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ALB—lung cancer	9.24e-05	0.000361	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—APOA1—lung cancer	8.92e-05	0.000348	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CB—lung cancer	8.81e-05	0.000344	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CB—lung cancer	8.81e-05	0.000344	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—AKT1—lung cancer	8.78e-05	0.000343	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP1A1—lung cancer	8.76e-05	0.000342	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTGS2—lung cancer	8.73e-05	0.000341	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTGS2—lung cancer	8.73e-05	0.000341	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ERCC2—lung cancer	8.69e-05	0.000339	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—APOA1—lung cancer	8.55e-05	0.000334	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CG—lung cancer	8.49e-05	0.000332	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTEN—lung cancer	8.36e-05	0.000327	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CB—lung cancer	8.16e-05	0.000319	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CG—lung cancer	8.14e-05	0.000318	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTGS2—lung cancer	8.08e-05	0.000316	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—POMC—lung cancer	8.08e-05	0.000316	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—EP300—lung cancer	7.98e-05	0.000312	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CREBBP—lung cancer	7.87e-05	0.000308	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CG—lung cancer	7.8e-05	0.000305	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—POMC—lung cancer	7.75e-05	0.000303	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTEN—lung cancer	7.61e-05	0.000297	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTEN—lung cancer	7.61e-05	0.000297	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CREBBP—lung cancer	7.55e-05	0.000295	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—APOA1—lung cancer	7.52e-05	0.000294	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CD—lung cancer	7.46e-05	0.000292	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—POMC—lung cancer	7.43e-05	0.00029	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALB—lung cancer	7.37e-05	0.000288	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—EP300—lung cancer	7.26e-05	0.000284	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—EP300—lung cancer	7.26e-05	0.000284	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CREBBP—lung cancer	7.24e-05	0.000283	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CD—lung cancer	7.16e-05	0.00028	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALB—lung cancer	7.06e-05	0.000276	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTEN—lung cancer	7.05e-05	0.000275	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CG—lung cancer	6.86e-05	0.000268	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CD—lung cancer	6.86e-05	0.000268	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALB—lung cancer	6.77e-05	0.000265	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—EP300—lung cancer	6.72e-05	0.000263	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—POMC—lung cancer	6.53e-05	0.000255	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CB—lung cancer	6.51e-05	0.000254	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTGS2—lung cancer	6.45e-05	0.000252	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CREBBP—lung cancer	6.36e-05	0.000249	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CB—lung cancer	6.24e-05	0.000244	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTGS2—lung cancer	6.18e-05	0.000242	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CD—lung cancer	6.03e-05	0.000236	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CB—lung cancer	5.98e-05	0.000234	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALB—lung cancer	5.95e-05	0.000233	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTGS2—lung cancer	5.93e-05	0.000232	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CA—lung cancer	5.9e-05	0.000231	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTEN—lung cancer	5.62e-05	0.00022	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTEN—lung cancer	5.39e-05	0.000211	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CA—lung cancer	5.37e-05	0.00021	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CA—lung cancer	5.37e-05	0.00021	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—EP300—lung cancer	5.36e-05	0.00021	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CB—lung cancer	5.26e-05	0.000205	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTGS2—lung cancer	5.21e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTEN—lung cancer	5.17e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—EP300—lung cancer	5.14e-05	0.000201	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CA—lung cancer	4.97e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—EP300—lung cancer	4.93e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—AKT1—lung cancer	4.82e-05	0.000188	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTEN—lung cancer	4.54e-05	0.000178	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—AKT1—lung cancer	4.39e-05	0.000171	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—AKT1—lung cancer	4.39e-05	0.000171	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—EP300—lung cancer	4.33e-05	0.000169	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—AKT1—lung cancer	4.06e-05	0.000159	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CA—lung cancer	3.97e-05	0.000155	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CA—lung cancer	3.8e-05	0.000149	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CA—lung cancer	3.65e-05	0.000142	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—AKT1—lung cancer	3.24e-05	0.000127	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CA—lung cancer	3.2e-05	0.000125	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—AKT1—lung cancer	3.11e-05	0.000121	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—AKT1—lung cancer	2.98e-05	0.000116	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AKT1—lung cancer	2.62e-05	0.000102	CbGpPWpGaD
